Table 1.
Baseline characteristics: comparing CMBs patients with non-CMBs patients.
| Variables | Total (n = 587) | Non-CMBs (n = 374) | CMBs (n = 213) | p |
|---|---|---|---|---|
| Age, n (%) | 0.003 | |||
| ≤63 | 303 (52) | 211 (56) | 92 (43) | |
| >63 | 284 (48) | 163 (44) | 121 (57) | |
| Hypertension, n (%) | <0.001 | |||
| Normal | 189 (32) | 161 (43) | 28 (13) | |
| Level 1 | 109 (19) | 73 (20) | 36 (17) | |
| Level 2 | 38 (6) | 22 (6) | 16 (8) | |
| Level 3 | 251 (43) | 118 (32) | 133 (62) | |
| Gender, n (%) | <0.001 | |||
| Female | 307 (52) | 229 (61) | 78 (37) | |
| Male | 280 (48) | 145 (39) | 135 (63) | |
| Stroke, n (%) | <0.001 | |||
| No | 443 (75) | 319 (85) | 124 (58) | |
| Yes | 144 (25) | 55 (15) | 89 (42) | |
| Carotid Atherosclerosis, n (%) | <0.001 | |||
| No | 245 (42) | 181 (48) | 64 (30) | |
| Yes | 342 (58) | 193 (52) | 149 (70) | |
| Creatinine (μmol/L), n (%) | <0.001 | |||
| ≤77 | 474 (81) | 330 (88) | 144 (68) | |
| >77 | 113 (19) | 44 (12) | 69 (32) | |
| Homocysteine, n (%) | <0.001 | |||
| ≤20 | 449 (76) | 311 (83) | 138 (65) | |
| >20 | 138 (24) | 63 (17) | 75 (35) | |
| Neutrophil to HDL Ratio, n (%) | <0.001 | |||
| ≤4.60 | 380 (65) | 269 (72) | 111 (52) | |
| >4.60 | 207 (35) | 105 (28) | 102 (48) | |
| White Blood Cell Count (×109/L), n (%) | 0.003 | |||
| ≤6.73 | 294 (50) | 205 (55) | 89 (42) | |
| >6.73 | 293 (50) | 169 (45) | 124 (58) | |
| Neutrophil Count (×109/L), n (%) | 0.02 | |||
| ≤4.36 | 295 (50) | 202 (54) | 93 (44) | |
| >4.36 | 292 (50) | 172 (46) | 120 (56) | |
| Monocyte Count (×109/L), n (%) | 0.02 | |||
| ≤0.44 | 295 (50) | 202 (54) | 93 (44) | |
| >0.44 | 292 (50) | 172 (46) | 120 (56) | |
| Uric Acid (μmol/L), n (%) | 0.019 | |||
| ≤298 | 298 (51) | 204 (55) | 94 (44) | |
| >298 | 289 (49) | 170 (45) | 119 (56) | |
| Calcium (mmol/L), n (%) | 0.002 | |||
| ≤2.32 | 310 (53) | 179 (48) | 131 (62) | |
| >2.32 | 277 (47) | 195 (52) | 82 (38) | |
| International Normalized Ratio, n (%) | 0.012 | |||
| ≤0.98 | 306 (52) | 210 (56) | 96 (45) | |
| >0.98 | 281 (48) | 164 (44) | 117 (55) | |
| Fibrinogen (g/L), n (%) | 0.027 | |||
| ≤2.88 | 296 (50) | 202 (54) | 94 (44) | |
| >2.88 | 291 (50) | 172 (46) | 119 (56) | |
| Apolipoprotein A1 (g/L), n (%) | 0.003 | |||
| ≤1.03 | 296 (50) | 171 (46) | 125 (59) | |
| >1.03 | 291 (50) | 203 (54) | 88 (41) | |
| Apolipoprotein B100 (g/L), n (%) | 0.001 | |||
| ≤0.79 | 297 (51) | 170 (45) | 127 (60) | |
| >0.79 | 290 (49) | 204 (55) | 86 (40) | |
| Apolipoprotein E (mg/L), n (%) | 0.002 | |||
| ≤37 | 296 (50) | 170 (45) | 126 (59) | |
| >37 | 291 (50) | 204 (55) | 87 (41) | |
| Lactate Dehydrogenase (U/L), n (%) | 0.017 | |||
| ≤158 | 307 (52) | 210 (56) | 97 (46) | |
| >158 | 280 (48) | 164 (44) | 116 (54) | |
| Albumin (g/L), n (%) | 0.005 | |||
| ≤39 | 377 (64) | 224 (60) | 153 (72) | |
| >39 | 210 (36) | 150 (40) | 60 (28) | |
| Direct Bilirubin (μmol/L), n (%) | 0.025 | |||
| ≤3.60 | 302 (51) | 206 (55) | 96 (45) | |
| >3.60 | 285 (49) | 168 (45) | 117 (55) | |
| Systemic Inflammation Response Index, n (%) | 0.028 | |||
| ≤1.23 | 293 (50) | 200 (53) | 93 (44) | |
| >1.23 | 294 (50) | 174 (47) | 120 (56) | |
| Urea (mmol/L), n (%) | <0.001 | |||
| ≤5.40 | 303 (52) | 213 (57) | 90 (42) | |
| >5.40 | 284 (48) | 161 (43) | 123 (58) | |
| Total Cholesterol, n (%) | <0.001 | |||
| ≤4.50 | 295 (50) | 166 (44) | 129 (61) | |
| >4.50 | 292 (50) | 208 (56) | 84 (39) | |
| High-Density Lipoprotein (mmol/L), n (%) | 0.002 | |||
| ≤1.13 | 306 (52) | 176 (47) | 130 (61) | |
| >1.13 | 281 (48) | 198 (53) | 83 (39) | |
| Low-Density Lipoprotein (mmol/L), n (%) | <0.001 | |||
| ≤2.89 | 295 (50) | 166 (44) | 129 (61) | |
| >2.89 | 292 (50) | 208 (56) | 84 (39) | |
| Lipoprotein(a) (mg/L), n (%) | 0.031 | |||
| ≤185 | 295 (50) | 201 (54) | 94 (44) | |
| >185 | 292 (50) | 173 (46) | 119 (56) | |
| Albumin to Globulin Ratio, n (%) | <0.001 | |||
| ≤1.50 | 304 (52) | 170 (45) | 134 (63) | |
| >1.50 | 283 (48) | 204 (55) | 79 (37) | |
| Lymphocyte-to-Monocyte Ratio, n (%) | 0.028 | |||
| ≤3.47 | 294 (50) | 174 (47) | 120 (56) | |
| >3.47 | 293 (50) | 200 (53) | 93 (44) | |
| Monocyte-to-HDL Ratio, n (%) | 0.004 | |||
| ≤0.39 | 293 (50) | 204 (55) | 89 (42) | |
| >0.39 | 294 (50) | 170 (45) | 124 (58) | |